The results of the study suggest that elevated leptin and resistin levels in OA are associated mainly with the localization of the osteoarthritic process in the knee joint in the context of accompanying obesity, i.e., metabolic knee OA, which could be considered as a potential new component of the metabolic syndrome. This evidence concerns the gene RETN and metabolic syndrome.